BCLI

BRAINSTORM CELL THERAPUTC
BCLI

Overview Fund Activity
Delisted

BCLI was delisted on the 17th of July, 2025.

Back to rankings

48 hedge funds and large institutions have $20.4M invested in BRAINSTORM CELL THERAPUTC in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 5 closing their positions.

Holders
48
Holders Change
+5
Holders Change %
+11.63%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
8
Reduced
8
Closed
5
Calls
$1.08M
Puts
$1.37M
Net Calls
-$285K
Net Calls Change
-$1M

Top Buyers

1
ACM
1
AIGH Capital Management
Maryland
$4.82M
2
WVP
2
Worth Venture Partners
New Jersey
$1.18M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$1.33M
4
Simplex Trading
4
Simplex Trading
Illinois
$605K
5
Group One Trading
5
Group One Trading
Illinois
$537K

Top Sellers

1
RJA
1
Raymond James & Associates
Florida
$544K
2
IA
2
IFP Advisors
Florida
$0
3
Millennium Management
3
Millennium Management
New York
$37K
4
Marshall Wace
4
Marshall Wace
United Kingdom
$0
5
Creative Planning
5
Creative Planning
Kansas
$46.2K
Name Holding Trade Value Shares
Change 		Shares
Change %
Jane Street
51
Jane Street
New York
– -$23K -937 Closed
Renaissance Technologies
52
Renaissance Technologies
New York
– -$19K -787 Closed
1 2
3